Health insurers extend decline on proposed new rule to curb fraud

By Reuters News

** Shares of health insurers fall for a second consecutive session after the Centers for Medicare & Medicaid Services proposed tighter audits and other measures targeting fraud and improper payments

** UnitedHealth UNH.N falls 9.6% to $352.26, Humana HUM.N 11.3% to $392.15 and Elevance Health ELV.N 6.9% to $403.74

** Molina Healthcare MOH.N declined 4.9% to $210.24, Centene CNC.N 6.7% to $67.65, CVS Health CVS.N 4.29% to $82.13 and Cigna CI.N 3.3% to $284.24

** The agency on Monday proposed expanding audits of Medicare Advantage plans and increasing scrutiny of deductions from payments to Medicaid insurers

** Morgan Stanley says the proposal could substantially increase repayments by allowing errors found in audit samples to be applied to the wider population represented by those samples

** Brokerage estimates potential repayments could equal 11% to 51% of its 2028 earnings estimates for UNH, HUM and CVS, though it says the impact remains highly uncertain and expects industry pushback

** Including session's move, UNH climbed 5.2%, HUM advanced 52.5%, ELV gained 14.5%, CVS added 3.5%, CNC rose 63.5%, MOH jumped 20.3% and CI was up 3.2% YTD

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.